DMAC - Company ID 0001401040
DiaMedica Therapeutics Inc. trades as DMAC. This page tracks DiaMedica Therapeutics Inc. through 414 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-21 |
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-06 |
| Annual report to shareholders | ARS | 2026-04-01 |
| Proxy materials | DEFA14A | 2026-04-01 |
| Proxy statement | DEF 14A | 2026-04-01 |
| Major company event | 8-K | 2026-03-31 |
| Annual report | 10-K | 2026-03-30 |
The largest companies sharing DiaMedica Therapeutics Inc.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year DiaMedica Therapeutics Inc. reported a net loss of $32.77M.